Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
Status:
NOT_YET_RECRUITING
Trial end date:
2027-01-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to to compare low dose of exemestane (babyexe) versus low dose of tamoxifen (babytam) in terms of change of quality of life from baseline to 12 months.
Phase:
PHASE2
Details
Lead Sponsor:
Andrea DeCensi
Collaborators:
Breast Cancer Research Foundation Dana-Farber/Brigham and Women's Cancer Center Herbert Irving Comprehensive Cancer Center Istituto Europeo di Oncologia